Evaluation of Depression Levels in Patients With Primary Open-Angle Glaucoma Using the Geriatric Depression Scale

Basit Öğe Kaydı
dc.contributor.authorOzer, Ayseguel Barak
dc.contributor.authorEroz, Pinar
dc.date.accessioned2024-11-07T13:25:14Z
dc.date.available2024-11-07T13:25:14Z
dc.date.issued2024
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractIntroduction Glaucoma is a chronic disease that can lead to severe visual impairment and blindness. Methods The study included 91 primary open-angle glaucoma patients aged 60 years and older (group 1) and 83 healthy controls (group 2) with similar age and gender distribution. The duration of the disease, the number of anti-glaucomatous drops used daily, and visual field parameters were recorded. All participants then underwent a comprehensive mental status examination by a psychiatrist and were administered the Geriatric Depression Scale (GDS). Results In Group 1, the mean duration of glaucoma was 10.2 +/- 6.0 years, and the mean number of drops used per day was 2.91 +/- 1.47 drops/day. According to visual field (24-2) data, the mean mean deviation (MD) was-7.76 +/- 4.78 dB and the mean pattern standard deviation (PSD) was 5.14 +/- 2.60 dB. According to the classification based on MD, 33 (36.3%) patients were in the early stage, 36 (39.5%) in the intermediate stage, and 22 (24.2%) in the advanced stage. The mean best-corrected visual acuity (BCVA) was 0.85 +/- 0.38 logMAR in group 1 and 0.34 +/- 0.19 logMAR in group 2. The mean GDS scores were 13.7 +/- 7.23 points in group 1 and 3.61 +/- 1.71 points in group 2. There were statistically significant differences between the groups in terms of BCVA and GDS scores (p=0.039 and p<0.001, respectively). Conclusion In conclusion, it is important that ophthalmologists provide adequate information about glaucoma to prevent the development of depression in patients with glaucoma. This information may protect patients from uncertainty. A multidisciplinary approach in the management of glaucoma, a chronic and vision-threatening disease, can positively affect patients' compliance with follow-up and treatment, increase the quality of healthcare, and improve treatment responses.
dc.identifier.doi10.7759/cureus.64162
dc.identifier.issn2168-8184
dc.identifier.issue7
dc.identifier.pmid39119439
dc.identifier.urihttps://doi.org/10.7759/cureus.64162
dc.identifier.urihttps://hdl.handle.net/11480/14560
dc.identifier.volume16
dc.identifier.wosWOS:001268515200011
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringernature
dc.relation.ispartofCureus Journal of Medical Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectvisual field defect
dc.subjectlow vision
dc.subjectage and depression
dc.subjectdepression in chronic illness
dc.subjectprimary open angle glaucoma
dc.titleEvaluation of Depression Levels in Patients With Primary Open-Angle Glaucoma Using the Geriatric Depression Scale
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu